Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Catalyst_Pharmaceuticals> ?p ?o }
Showing triples 1 to 77 of
77
with 100 triples per page.
- Catalyst_Pharmaceuticals abstract "Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including Firdapse (3,4-diaminopyridine phosphate, a potassium channel blocker) for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.".
- Catalyst_Pharmaceuticals assets "4.39E7".
- Catalyst_Pharmaceuticals equity "3.52E7".
- Catalyst_Pharmaceuticals industry Biotechnology.
- Catalyst_Pharmaceuticals locationCity Coral_Gables,_Florida.
- Catalyst_Pharmaceuticals locationCountry United_States.
- Catalyst_Pharmaceuticals numberOfEmployees "20".
- Catalyst_Pharmaceuticals operatingIncome "-1.55E7".
- Catalyst_Pharmaceuticals revenue "0.0".
- Catalyst_Pharmaceuticals type Public_company.
- Catalyst_Pharmaceuticals wikiPageExternalLink www.catalystpharma.com.
- Catalyst_Pharmaceuticals wikiPageID "47623368".
- Catalyst_Pharmaceuticals wikiPageLength "10079".
- Catalyst_Pharmaceuticals wikiPageOutDegree "21".
- Catalyst_Pharmaceuticals wikiPageRevisionID "696437175".
- Catalyst_Pharmaceuticals wikiPageWikiLink 3,4-Diaminopyridine.
- Catalyst_Pharmaceuticals wikiPageWikiLink BioMarin_Pharmaceutical.
- Catalyst_Pharmaceuticals wikiPageWikiLink Biopharmaceutical.
- Catalyst_Pharmaceuticals wikiPageWikiLink Biotechnology.
- Catalyst_Pharmaceuticals wikiPageWikiLink Breakthrough_therapy.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Companies_based_in_Miami-Dade_County,_Florida.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Orphan_drug_companies.
- Catalyst_Pharmaceuticals wikiPageWikiLink Category:Pharmaceutical_companies_established_in_2002.
- Catalyst_Pharmaceuticals wikiPageWikiLink Congenital_myasthenic_syndrome.
- Catalyst_Pharmaceuticals wikiPageWikiLink Coral_Gables,_Florida.
- Catalyst_Pharmaceuticals wikiPageWikiLink Epileptic_spasms.
- Catalyst_Pharmaceuticals wikiPageWikiLink GABA_transaminase.
- Catalyst_Pharmaceuticals wikiPageWikiLink Lambert–Eaton_myasthenic_syndrome.
- Catalyst_Pharmaceuticals wikiPageWikiLink Orphan_drug.
- Catalyst_Pharmaceuticals wikiPageWikiLink Potassium_channel_blocker.
- Catalyst_Pharmaceuticals wikiPageWikiLink Public_company.
- Catalyst_Pharmaceuticals wikiPageWikiLink United_States.
- Catalyst_Pharmaceuticals wikiPageWikiLinkText "Catalyst Pharmaceuticals".
- Catalyst_Pharmaceuticals assets "4.39E7".
- Catalyst_Pharmaceuticals equity "3.52E7".
- Catalyst_Pharmaceuticals homepage www.catalystpharma.com.
- Catalyst_Pharmaceuticals industry Biotechnology.
- Catalyst_Pharmaceuticals keyPeople "Patrick J. McEnany, Co-Founder, Chairman, President and Chief Executive Officer".
- Catalyst_Pharmaceuticals locationCity Coral_Gables,_Florida.
- Catalyst_Pharmaceuticals locationCountry United_States.
- Catalyst_Pharmaceuticals name "Catalyst Pharmaceutical Partners, Inc.".
- Catalyst_Pharmaceuticals numEmployees "--03-20".
- Catalyst_Pharmaceuticals operatingIncome "-1.55E7".
- Catalyst_Pharmaceuticals products "in development".
- Catalyst_Pharmaceuticals revenue "0.0".
- Catalyst_Pharmaceuticals type Public_company.
- Catalyst_Pharmaceuticals wikiPageUsesTemplate Template:Decrease.
- Catalyst_Pharmaceuticals wikiPageUsesTemplate Template:Increase.
- Catalyst_Pharmaceuticals wikiPageUsesTemplate Template:Infobox_company.
- Catalyst_Pharmaceuticals wikiPageUsesTemplate Template:NASDAQ.
- Catalyst_Pharmaceuticals wikiPageUsesTemplate Template:Reflist.
- Catalyst_Pharmaceuticals subject Category:Biotechnology_companies_of_the_United_States.
- Catalyst_Pharmaceuticals subject Category:Companies_based_in_Miami-Dade_County,_Florida.
- Catalyst_Pharmaceuticals subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Catalyst_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- Catalyst_Pharmaceuticals subject Category:Orphan_drug_companies.
- Catalyst_Pharmaceuticals subject Category:Pharmaceutical_companies_established_in_2002.
- Catalyst_Pharmaceuticals hypernym Company.
- Catalyst_Pharmaceuticals type Agent.
- Catalyst_Pharmaceuticals type Company.
- Catalyst_Pharmaceuticals type Organisation.
- Catalyst_Pharmaceuticals type Organization.
- Catalyst_Pharmaceuticals type Agent.
- Catalyst_Pharmaceuticals type SocialPerson.
- Catalyst_Pharmaceuticals type Thing.
- Catalyst_Pharmaceuticals type Q43229.
- Catalyst_Pharmaceuticals comment "Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including Firdapse (3,4-diaminopyridine phosphate, a potassium channel blocker) for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.".
- Catalyst_Pharmaceuticals label "Catalyst Pharmaceuticals".
- Catalyst_Pharmaceuticals sameAs Q18149200.
- Catalyst_Pharmaceuticals sameAs Q18149200.
- Catalyst_Pharmaceuticals wasDerivedFrom Catalyst_Pharmaceuticals?oldid=696437175.
- Catalyst_Pharmaceuticals homepage www.catalystpharma.com.
- Catalyst_Pharmaceuticals isPrimaryTopicOf Catalyst_Pharmaceuticals.
- Catalyst_Pharmaceuticals name "Catalyst Pharmaceutical Partners, Inc.".